Clinical Trial Update: Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the pharmacodynamic effects of candesartan, atenolol, hydrochlorothiazide, and their combinations in hypertensive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atenolol (Atenolol)
• Candesartan (candesartan)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Hypertension | Phase 4 | Status: COMPLETED